LIMINATUS PHARMA INC-CL A (LIMN) Stock Cash Flow
NASDAQ:LIMN • US53271X1081
0.2562 USD
-0.12 (-31.86%)
At close: Feb 17, 2026
0.2639 USD
+0.01 (+3.01%)
Pre-Market: 2/18/2026, 8:37:58 AM
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -2.91M | -2.90M | -1.23M | 10.25M | 4.37M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | N/A | |||
| Change In Working Capital | -7.50M | 2.10M | 1.64M | 1.16M | 1.32M | |||
| Interest Paid | N/A | 0.00 | 0.00 | 503.00K | N/A | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 0.00 | N/A | |||
| Other non cash items | N/A | -157.60K | 0.00 | 900.00K | -6.90M | |||
| OPERATING CASH FLOW | -10.36M | -1.45M | -3.35M | -869.00K | -1.22M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | -832.30K | -2.85M | -819.00K | 0.00 | -276.00M | |||
| INVESTING CASH FLOW | -845.40K | -2.85M | -819.00K | 0.00 | -276.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 3.59M | 3.92M | -450.00K | 2.42M | N/A | |||
| Stock Issued/Repurchased | N/A | -1.80M | -10.66M | 3.50M | 283.07M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | -5.52M | |||
| FINANCING CASH FLOW | 11.58M | 3.92M | -450.00K | 5.92M | 277.55M | |||
| CHANGE IN CASH | 375.40K | -378.00K | -4.61M | 5.05M | 330.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.36M | -1.45M | -3.35M | -869.00K | -1.22M | |||
| FREE CASH FLOW | -10.38M | -1.45M | -3.35M | -869.00K | -1.22M | |||
All data in USD